Related references
Note: Only part of the references are listed.CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line
Xingjun Feng et al.
TUMOR BIOLOGY (2014)
Astrocyte elevated gene-1 activates MMP9 to increase invasiveness of colorectal cancer
Hongtao Song et al.
TUMOR BIOLOGY (2014)
SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer
Hong Jian et al.
TUMOR BIOLOGY (2014)
Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK-Mediated Up-Regulation of MMP-2 and MMP-9
Qian-ze Dong et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal
Yoshitaka Michifuri et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells
Yang Liu et al.
TUMOR BIOLOGY (2013)
Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis
Jianming Liu et al.
TUMOR BIOLOGY (2012)
Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer
Qian-Ze Dong et al.
CANCER SCIENCE (2010)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer
K Akino et al.
GASTROENTEROLOGY (2005)
RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family
K Eckfeld et al.
CANCER RESEARCH (2004)
RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population
IJ Fidler et al.
NATURE GENETICS (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
